Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
Steinstraesser, A., Schmidt, R., Bergmann, K., Dahmen, R., Becker, R. H. A.
Published in Diabetes, obesity & metabolism (01.09.2014)
Published in Diabetes, obesity & metabolism (01.09.2014)
Get full text
Journal Article
Pharmacokinetic and glucodynamic variability : assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique
SCHOLTZ, H. E, PRETORIUS, S. G, WESSELS, D. H, BECKER, R. H. A
Published in Diabetologia (01.10.2005)
Published in Diabetologia (01.10.2005)
Get full text
Journal Article
Low within- and between-day variability in exposure to new insulin glargine 300 U/ml
Becker, R. H. A., Nowotny, I., Teichert, L., Bergmann, K., Kapitza, C.
Published in Diabetes, obesity & metabolism (01.03.2015)
Published in Diabetes, obesity & metabolism (01.03.2015)
Get full text
Journal Article
Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects
Becker, R H A, Frick, A D, Burger, F, Potgieter, J H, Scholtz, H
Published in Experimental and clinical endocrinology & diabetes (01.09.2005)
Published in Experimental and clinical endocrinology & diabetes (01.09.2005)
Get more information
Journal Article
Single-dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes
Shiramoto, M., Eto, T., Irie, S., Fukuzaki, A., Teichert, L., Tillner, J., Takahashi, Y., Koyama, M., Dahmen, R., Heise, T., Becker, R. H. A.
Published in Diabetes, obesity & metabolism (01.03.2015)
Published in Diabetes, obesity & metabolism (01.03.2015)
Get full text
Journal Article
A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique
Becker, R H A, Frick, A D, Burger, F, Scholtz, H, Potgieter, J H
Published in Experimental and clinical endocrinology & diabetes (01.05.2005)
Published in Experimental and clinical endocrinology & diabetes (01.05.2005)
Get more information
Journal Article
Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes - a study in both people with type 2 diabetes and healthy subjects
Becker, R. H. A., Stechl, J., Msihid, J., Kapitza, C.
Published in Diabetes, obesity & metabolism (01.09.2014)
Published in Diabetes, obesity & metabolism (01.09.2014)
Get full text
Journal Article
A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes
Marbury, T C, Schwartz, S, Rosenberg, M A, Jariwala, N, Becker, R H A, Johnston, P S
Published in Experimental and clinical endocrinology & diabetes (01.05.2008)
Published in Experimental and clinical endocrinology & diabetes (01.05.2008)
Get more information
Journal Article
Insulin glulisine: a faster onset of action compared with insulin lispro
Heise, T., Nosek, L., Spitzer, H., Heinemann, L., Niemöller, E., Frick, A. D., Becker, R. H. A.
Published in Diabetes, obesity & metabolism (01.09.2007)
Published in Diabetes, obesity & metabolism (01.09.2007)
Get full text
Journal Article
Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects
Becker, R.H.A, Frick, A.D, Teichert, L, Nosek, L, Heinemann, L, Heise, T, Rave, K
Published in Diabetes, obesity & metabolism (01.11.2008)
Published in Diabetes, obesity & metabolism (01.11.2008)
Get full text
Journal Article
Single-dose new insulin glargine 300U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes
Shiramoto, M, Eto, T, Irie, S, Fukuzaki, A, Teichert, L, Tillner, J, Takahashi, Y, Koyama, M, Dahmen, R, Heise, T, Becker, R H A
Published in Diabetes, obesity & metabolism (01.03.2015)
Published in Diabetes, obesity & metabolism (01.03.2015)
Get full text
Journal Article
Single‐dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in J apanese and E uropean people with type 1 diabetes
Shiramoto, M., Eto, T., Irie, S., Fukuzaki, A., Teichert, L., Tillner, J., Takahashi, Y., Koyama, M., Dahmen, R., Heise, T., Becker, R. H. A.
Published in Diabetes, obesity & metabolism (01.03.2015)
Published in Diabetes, obesity & metabolism (01.03.2015)
Get full text
Journal Article
Dose-response relationship of insulin glulisine in subjects with type 1 diabetes
Becker, R.H.A, Frick, A.D, Teichert, L, Nosek, L, Heinemann, L, Rave, K
Published in Diabetes, obesity & metabolism (2009)
Published in Diabetes, obesity & metabolism (2009)
Get full text
Journal Article
Long-term ACE inhibition doubles lifespan of hypertensive rats
LINZ, W, JESSEN, T, BECKER, R. H. A, SHÖLKENS, B. A, WIEMER, G
Published in Circulation (New York, N.Y.) (04.11.1997)
Published in Circulation (New York, N.Y.) (04.11.1997)
Get full text
Journal Article